“erectile dysfunction treatment”的搜索结果，显示 831-840 项，共有 12324 项

1. 外科 - 临床试验- 妙佑医疗国际

   ... treatment or patients that are experiencing an upper digestive disease in ... treatment and have a positive 68Ga-PSMA-11 PET scan. The purpose of this ...

2. 肾病和高血压- 临床试验- 妙佑医疗国际

   ... treatment and may reduce the burden of cancer and ... Study to Evaluate Clinical Complications, Pattern of Kidney Function ... Study to Evaluate Clinical ...

3. 神经科- 临床试验- 妙佑医疗国际

   Patients in cohorts 1.11 and 1.12 (currently lacking detectable cancer) will undergo the collection at least 4 weeks after conclusion of therapy. In addition to ...

4. 神经科- 临床试验- 妙佑医疗国际

   Patients in cohorts 1.11 and 1.12 (currently lacking detectable cancer) will undergo the collection at least 4 weeks after conclusion of therapy. In addition to ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... function, assessed with a Mini-mental State ... treatment of patients with biopsy-proven high grade glioma prior to conventional therapy. ... A Study To Compare ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small lymphocytic lymphoma. Durvalumab is FDA approved for treatment in lung ...

7. 脑深部刺激- 医生与科室- 妙佑医疗国际

   Brief statement: Medtronic DBS Therapy for Parkinson's disease, tremor, dystonia, obsessive-compulsive disorder and epilepsy. Medtronic. https://www.medtronic.

8. 心血管医学- 临床试验- 妙佑医疗国际

   Treatment for FSGS is considered unsuccessful if the patient is unresponsive to standard therapy (e.g., at least 8 weeks of corticosteroids) and fails to ...

9. 神经科- 临床试验- 妙佑医疗国际

   Patients in cohorts 1.11 and 1.12 (currently lacking detectable cancer) will undergo the collection at least 4 weeks after conclusion of therapy. In addition to ...

10. 神经科- 临床试验- 妙佑医疗国际

    Patients in cohorts 1.11 and 1.12 (currently lacking detectable cancer) will undergo the collection at least 4 weeks after conclusion of therapy. In addition to ...